The global Spinal Muscular Atrophy (SMA) Treatment market was valued at US$ 941.9 million in 2022 and is projected to reach US$ 1511.1 million by 2029, at a CAGR of 7.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Spinal muscular atrophy (SMA) refers to a group of inherited diseases that affects the functioning of muscles because of deterioration.
This report aims to provide a comprehensive presentation of the global market for Spinal Muscular Atrophy (SMA) Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Spinal Muscular Atrophy (SMA) Treatment. This report contains market size and forecasts of Spinal Muscular Atrophy (SMA) Treatment in global, including the following market information:
- Global Spinal Muscular Atrophy (SMA) Treatment Market Revenue, 2018-2023, 2024-2032, ($ millions)
- Global top five companies in 2022 (%)
North America dominates the global market for SMA treatment due to the high prevalence of SMA and increased adoption of SMA treatment options in the region.
We surveyed the Spinal Muscular Atrophy (SMA) Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Spinal Muscular Atrophy (SMA) Treatment Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Spinal Muscular Atrophy (SMA) Treatment Market Segment Percentages, by Type, 2022 (%)
- Type I Spinal Muscular Atrophy (SMA)
- Type II Spinal Muscular Atrophy (SMA)
- Type III Spinal Muscular Atrophy (SMA)
Global Spinal Muscular Atrophy (SMA) Treatment Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Spinal Muscular Atrophy (SMA) Treatment Market Segment Percentages, by Application, 2022 (%)
- Hospitals
- Ambulatory Surgical Centers
- Diagnostic Centers
- Others
Global Spinal Muscular Atrophy (SMA) Treatment Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Spinal Muscular Atrophy (SMA) Treatment Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Spinal Muscular Atrophy (SMA) Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Spinal Muscular Atrophy (SMA) Treatment revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Pfizer
- Isis Pharmaceuticals
- Biogen Idec
- Boehringer Ingelheim
- F. Hoffmann-La Roche
- Regeneron Pharmaceuticals
Outline of Major Chapters:
- Chapter 1: Introduces the definition of Spinal Muscular Atrophy (SMA) Treatment, market overview.
- Chapter 2: Global Spinal Muscular Atrophy (SMA) Treatment market size in revenue.
- Chapter 3: Detailed analysis of Spinal Muscular Atrophy (SMA) Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
- Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter 6: Sales of Spinal Muscular Atrophy (SMA) Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
- Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
- Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Spinal Muscular Atrophy (SMA) Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Spinal Muscular Atrophy (SMA) Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Spinal Muscular Atrophy (SMA) Treatment Overall Market Size
2.1 Global Spinal Muscular Atrophy (SMA) Treatment Market Size: 2022 VS 2032
2.2 Global Spinal Muscular Atrophy (SMA) Treatment Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Spinal Muscular Atrophy (SMA) Treatment Players in Global Market
3.2 Top Global Spinal Muscular Atrophy (SMA) Treatment Companies Ranked by Revenue
3.3 Global Spinal Muscular Atrophy (SMA) Treatment Revenue by Companies
3.4 Top 3 and Top 5 Spinal Muscular Atrophy (SMA) Treatment Companies in Global Market, by Revenue in 2022
3.5 Global Companies Spinal Muscular Atrophy (SMA) Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Spinal Muscular Atrophy (SMA) Treatment Players in Global Market
3.6.1 List of Global Tier 1 Spinal Muscular Atrophy (SMA) Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Spinal Muscular Atrophy (SMA) Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Spinal Muscular Atrophy (SMA) Treatment Market Size Markets, 2022 & 2032
4.1.2 Type I Spinal Muscular Atrophy (SMA)
4.1.3 Type II Spinal Muscular Atrophy (SMA)
4.1.4 Type III Spinal Muscular Atrophy (SMA)
4.2 By Type - Global Spinal Muscular Atrophy (SMA) Treatment Revenue & Forecasts
4.2.1 By Type - Global Spinal Muscular Atrophy (SMA) Treatment Revenue, 2018-2023
4.2.2 By Type - Global Spinal Muscular Atrophy (SMA) Treatment Revenue, 2024-2032
4.2.3 By Type - Global Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Spinal Muscular Atrophy (SMA) Treatment Market Size, 2022 & 2032
5.1.2 Hospitals
5.1.3 Ambulatory Surgical Centers
5.1.4 Diagnostic Centers
5.1.5 Others
5.2 By Application - Global Spinal Muscular Atrophy (SMA) Treatment Revenue & Forecasts
5.2.1 By Application - Global Spinal Muscular Atrophy (SMA) Treatment Revenue, 2018-2023
5.2.2 By Application - Global Spinal Muscular Atrophy (SMA) Treatment Revenue, 2024-2032
5.2.3 By Application - Global Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Spinal Muscular Atrophy (SMA) Treatment Market Size, 2022 & 2032
6.2 By Region - Global Spinal Muscular Atrophy (SMA) Treatment Revenue & Forecasts
6.2.1 By Region - Global Spinal Muscular Atrophy (SMA) Treatment Revenue, 2018-2023
6.2.2 By Region - Global Spinal Muscular Atrophy (SMA) Treatment Revenue, 2024-2032
6.2.3 By Region - Global Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Spinal Muscular Atrophy (SMA) Treatment Revenue, 2018-2032
6.3.2 US Spinal Muscular Atrophy (SMA) Treatment Market Size, 2018-2032
6.3.3 Canada Spinal Muscular Atrophy (SMA) Treatment Market Size, 2018-2032
6.3.4 Mexico Spinal Muscular Atrophy (SMA) Treatment Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Spinal Muscular Atrophy (SMA) Treatment Revenue, 2018-2032
6.4.2 Germany Spinal Muscular Atrophy (SMA) Treatment Market Size, 2018-2032
6.4.3 France Spinal Muscular Atrophy (SMA) Treatment Market Size, 2018-2032
6.4.4 U.K. Spinal Muscular Atrophy (SMA) Treatment Market Size, 2018-2032
6.4.5 Italy Spinal Muscular Atrophy (SMA) Treatment Market Size, 2018-2032
6.4.6 Russia Spinal Muscular Atrophy (SMA) Treatment Market Size, 2018-2032
6.4.7 Nordic Countries Spinal Muscular Atrophy (SMA) Treatment Market Size, 2018-2032
6.4.8 Benelux Spinal Muscular Atrophy (SMA) Treatment Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Spinal Muscular Atrophy (SMA) Treatment Revenue, 2018-2032
6.5.2 China Spinal Muscular Atrophy (SMA) Treatment Market Size, 2018-2032
6.5.3 Japan Spinal Muscular Atrophy (SMA) Treatment Market Size, 2018-2032
6.5.4 South Korea Spinal Muscular Atrophy (SMA) Treatment Market Size, 2018-2032
6.5.5 Southeast Asia Spinal Muscular Atrophy (SMA) Treatment Market Size, 2018-2032
6.5.6 India Spinal Muscular Atrophy (SMA) Treatment Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Spinal Muscular Atrophy (SMA) Treatment Revenue, 2018-2032
6.6.2 Brazil Spinal Muscular Atrophy (SMA) Treatment Market Size, 2018-2032
6.6.3 Argentina Spinal Muscular Atrophy (SMA) Treatment Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Revenue, 2018-2032
6.7.2 Turkey Spinal Muscular Atrophy (SMA) Treatment Market Size, 2018-2032
6.7.3 Israel Spinal Muscular Atrophy (SMA) Treatment Market Size, 2018-2032
6.7.4 Saudi Arabia Spinal Muscular Atrophy (SMA) Treatment Market Size, 2018-2032
6.7.5 UAE Spinal Muscular Atrophy (SMA) Treatment Market Size, 2018-2032
7 Spinal Muscular Atrophy (SMA) Treatment Companies Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Spinal Muscular Atrophy (SMA) Treatment Major Product Offerings
7.1.4 Pfizer Spinal Muscular Atrophy (SMA) Treatment Revenue in Global Market (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Isis Pharmaceuticals
7.2.1 Isis Pharmaceuticals Company Summary
7.2.2 Isis Pharmaceuticals Business Overview
7.2.3 Isis Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Major Product Offerings
7.2.4 Isis Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Revenue in Global Market (2018-2023)
7.2.5 Isis Pharmaceuticals Key News & Latest Developments
7.3 Biogen Idec
7.3.1 Biogen Idec Company Summary
7.3.2 Biogen Idec Business Overview
7.3.3 Biogen Idec Spinal Muscular Atrophy (SMA) Treatment Major Product Offerings
7.3.4 Biogen Idec Spinal Muscular Atrophy (SMA) Treatment Revenue in Global Market (2018-2023)
7.3.5 Biogen Idec Key News & Latest Developments
7.4 Boehringer Ingelheim
7.4.1 Boehringer Ingelheim Company Summary
7.4.2 Boehringer Ingelheim Business Overview
7.4.3 Boehringer Ingelheim Spinal Muscular Atrophy (SMA) Treatment Major Product Offerings
7.4.4 Boehringer Ingelheim Spinal Muscular Atrophy (SMA) Treatment Revenue in Global Market (2018-2023)
7.4.5 Boehringer Ingelheim Key News & Latest Developments
7.5 F. Hoffmann-La Roche
7.5.1 F. Hoffmann-La Roche Company Summary
7.5.2 F. Hoffmann-La Roche Business Overview
7.5.3 F. Hoffmann-La Roche Spinal Muscular Atrophy (SMA) Treatment Major Product Offerings
7.5.4 F. Hoffmann-La Roche Spinal Muscular Atrophy (SMA) Treatment Revenue in Global Market (2018-2023)
7.5.5 F. Hoffmann-La Roche Key News & Latest Developments
7.6 Regeneron Pharmaceuticals
7.6.1 Regeneron Pharmaceuticals Company Summary
7.6.2 Regeneron Pharmaceuticals Business Overview
7.6.3 Regeneron Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Major Product Offerings
7.6.4 Regeneron Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Revenue in Global Market (2018-2023)
7.6.5 Regeneron Pharmaceuticals Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Spinal Muscular Atrophy (SMA) Treatment Market Opportunities & Trends in Global Market
Table 2. Spinal Muscular Atrophy (SMA) Treatment Market Drivers in Global Market
Table 3. Spinal Muscular Atrophy (SMA) Treatment Market Restraints in Global Market
Table 4. Key Players of Spinal Muscular Atrophy (SMA) Treatment in Global Market
Table 5. Top Spinal Muscular Atrophy (SMA) Treatment Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Spinal Muscular Atrophy (SMA) Treatment Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Spinal Muscular Atrophy (SMA) Treatment Revenue Share by Companies, 2018-2023
Table 8. Global Companies Spinal Muscular Atrophy (SMA) Treatment Product Type
Table 9. List of Global Tier 1 Spinal Muscular Atrophy (SMA) Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Spinal Muscular Atrophy (SMA) Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Spinal Muscular Atrophy (SMA) Treatment Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Spinal Muscular Atrophy (SMA) Treatment Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Spinal Muscular Atrophy (SMA) Treatment Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Spinal Muscular Atrophy (SMA) Treatment Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Spinal Muscular Atrophy (SMA) Treatment Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Spinal Muscular Atrophy (SMA) Treatment Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2024-2032
Table 30. Pfizer Company Summary
Table 31. Pfizer Spinal Muscular Atrophy (SMA) Treatment Product Offerings
Table 32. Pfizer Spinal Muscular Atrophy (SMA) Treatment Revenue (US$, Mn) & (2018-2023)
Table 33. Pfizer Key News & Latest Developments
Table 34. Isis Pharmaceuticals Company Summary
Table 35. Isis Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Product Offerings
Table 36. Isis Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Revenue (US$, Mn) & (2018-2023)
Table 37. Isis Pharmaceuticals Key News & Latest Developments
Table 38. Biogen Idec Company Summary
Table 39. Biogen Idec Spinal Muscular Atrophy (SMA) Treatment Product Offerings
Table 40. Biogen Idec Spinal Muscular Atrophy (SMA) Treatment Revenue (US$, Mn) & (2018-2023)
Table 41. Biogen Idec Key News & Latest Developments
Table 42. Boehringer Ingelheim Company Summary
Table 43. Boehringer Ingelheim Spinal Muscular Atrophy (SMA) Treatment Product Offerings
Table 44. Boehringer Ingelheim Spinal Muscular Atrophy (SMA) Treatment Revenue (US$, Mn) & (2018-2023)
Table 45. Boehringer Ingelheim Key News & Latest Developments
Table 46. F. Hoffmann-La Roche Company Summary
Table 47. F. Hoffmann-La Roche Spinal Muscular Atrophy (SMA) Treatment Product Offerings
Table 48. F. Hoffmann-La Roche Spinal Muscular Atrophy (SMA) Treatment Revenue (US$, Mn) & (2018-2023)
Table 49. F. Hoffmann-La Roche Key News & Latest Developments
Table 50. Regeneron Pharmaceuticals Company Summary
Table 51. Regeneron Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Product Offerings
Table 52. Regeneron Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Revenue (US$, Mn) & (2018-2023)
Table 53. Regeneron Pharmaceuticals Key News & Latest Developments
List of Figures
Figure 1. Spinal Muscular Atrophy (SMA) Treatment Segment by Type in 2022
Figure 2. Spinal Muscular Atrophy (SMA) Treatment Segment by Application in 2022
Figure 3. Global Spinal Muscular Atrophy (SMA) Treatment Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Spinal Muscular Atrophy (SMA) Treatment Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Spinal Muscular Atrophy (SMA) Treatment Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Spinal Muscular Atrophy (SMA) Treatment Revenue in 2022
Figure 8. By Type - Global Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share, 2018-2032
Figure 9. By Application - Global Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share, 2018-2032
Figure 10. By Type - Global Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share, 2018-2032
Figure 12. By Application - Global Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share, 2018-2032
Figure 14. By Region - Global Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share, 2018-2032
Figure 15. By Country - North America Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share, 2018-2032
Figure 16. US Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share, 2018-2032
Figure 20. Germany Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2018-2032
Figure 21. France Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share, 2018-2032
Figure 28. China Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2018-2032
Figure 32. India Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share, 2018-2032
Figure 34. Brazil Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share, 2018-2032
Figure 37. Turkey Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2018-2032
Figure 41. Pfizer Spinal Muscular Atrophy (SMA) Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Isis Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Biogen Idec Spinal Muscular Atrophy (SMA) Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Boehringer Ingelheim Spinal Muscular Atrophy (SMA) Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. F. Hoffmann-La Roche Spinal Muscular Atrophy (SMA) Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Regeneron Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
